Oslo University Hospital
Oslo, 0424, Norway
NCT Number: NCT04345536
Covid-19 is a recently emerging infectious disease with a very large impact on health care world-wide. The disease is still poorly described. It is an urgent need for better clinical characteristics. A prospective, quality register is therefore established for increasing the knowledge about the disease, the covid patients and the prognosis.
Looking for future studies?
Notify MeAll sexes
Observational
Oslo, 0424, Norway
All patient hospitalized at Oslo University Hospital, Ullevål, is prospectively registered in the approved quality register. Background, clinical and paraclinical data is harvested and registered, as well as treatment and mortality.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 month
Mortality in hospitalized covid patients
Time frame: 2 weeks
Number of patients with severe disease
Oslo University Hospital
Other
Acronym: CovidRegOUH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04481633
COVID-19, Coronaviridae Infections
Limoges, France
View Trial DetailsNCT07128069
COVID-19, Coronaviridae Infections
Chicago, Illinois, United States
View Trial DetailsNCT07222384
COVID-19, Coronaviridae Infections
Palo Alto, California, United States
View Trial DetailsNCT05543616
COVID-19, Coronaviridae Infections
Birmingham, Alabama, United States
View Trial Details